Give Progesterone a Chance
Overview
Affiliations
There is currently no standard pharmacological treatment for spinal cord injury. Here, we suggest that progesterone, a steroid hormone, may be a promising therapeutical candidate as it is already for traumatic brain injury, where it has reached phase II clinical trials. We rely on previous works showing anti-inflammatory, neuroprotective and promyelinating roles for progesterone after spinal cord injury and in our recent paper, in which we demonstrate that progesterone diminishes lesion, preserves white matter integrity and improves locomotor recovery in a clinically relevant model of spinal cord lesion.
Hormonal Regulation of Oligodendrogenesis II: Implications for Myelin Repair.
Breton J, Long K, Barraza M, Perloff O, Kaufer D Biomolecules. 2021; 11(2).
PMID: 33669242 PMC: 7919830. DOI: 10.3390/biom11020290.
Progesterone through Progesterone Receptor B Isoform Promotes Rodent Embryonic Oligodendrogenesis.
Gonzalez-Orozco J, Del Moral-Morales A, Camacho-Arroyo I Cells. 2020; 9(4).
PMID: 32295179 PMC: 7226962. DOI: 10.3390/cells9040960.
Age and Sex-Related Changes to Gene Expression in the Mouse Spinal Cord.
McCallum-Loudeac J, Anderson G, Wilson M J Mol Neurosci. 2019; 69(3):419-432.
PMID: 31267314 DOI: 10.1007/s12031-019-01371-3.
Sex steroid hormones and brain function: PET imaging as a tool for research.
Moraga-Amaro R, van Waarde A, Doorduin J, de Vries E J Neuroendocrinol. 2017; 30(2).
PMID: 29237239 PMC: 5838537. DOI: 10.1111/jne.12565.
TRPV1 may increase the effectiveness of estrogen therapy on neuroprotection and neuroregeneration.
Ramirez-Barrantes R, Marchant I, Olivero P Neural Regen Res. 2016; 11(8):1204-7.
PMID: 27651755 PMC: 5020806. DOI: 10.4103/1673-5374.189162.